Table 2.
Clinical Outcome
All patients (N=13) | |
---|---|
Best response on lenvatinib (N) | |
Complete response | 0 |
Partial response | 4 |
Stable disease | 4 |
Progressive disease | 1 |
not evaluable | 4 |
Duration of lenvatinib treatment (months) - median (range) | 5 (1-18+) |
Ongoing (N) | 6 |
Terminated (N) | 7 |